Global and United States Rapid Acting Insulins Market Report & Forecast 2022-2028
Table of Contents1 Study Coverage
1.1 Rapid Acting Insulins Revenue in Rapid Acting Insulins Business (2017-2022) & (US$ Million) Introduction
1.2 Global Rapid Acting Insulins Outlook 2017 VS 2022 VS 2028
1.2.1 Global Rapid Acting Insulins Market Size for the Year 2017-2028
1.2.2 Global Rapid Acting Insulins Market Size for the Year 2017-2028
1.3 Rapid Acting Insulins Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Rapid Acting Insulins in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Rapid Acting Insulins Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Rapid Acting Insulins Market Dynamics
1.4.1 Rapid Acting Insulins Industry Trends
1.4.2 Rapid Acting Insulins Market Drivers
1.4.3 Rapid Acting Insulins Market Challenges
1.4.4 Rapid Acting Insulins Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Rapid Acting Insulins by Type
2.1 Rapid Acting Insulins Market Segment by Type
2.1.1 Lispro
2.1.2 Aspart (NovoLog)
2.1.3 Glulisine (Apidra)
2.2 Global Rapid Acting Insulins Market Size by Type (2017, 2022 & 2028)
2.3 Global Rapid Acting Insulins Market Size by Type (2017-2028)
2.4 United States Rapid Acting Insulins Market Size by Type (2017, 2022 & 2028)
2.5 United States Rapid Acting Insulins Market Size by Type (2017-2028)
3 Rapid Acting Insulins by Application
3.1 Rapid Acting Insulins Market Segment by Application
3.1.1 Type 1 Diabetes
3.1.2 Type 2 Diabetes
3.2 Global Rapid Acting Insulins Market Size by Application (2017, 2022 & 2028)
3.3 Global Rapid Acting Insulins Market Size by Application (2017-2028)
3.4 United States Rapid Acting Insulins Market Size by Application (2017, 2022 & 2028)
3.5 United States Rapid Acting Insulins Market Size by Application (2017-2028)
4 Global Rapid Acting Insulins Competitor Landscape by Company
4.1 Global Rapid Acting Insulins Market Size by Company
4.1.1 Top Global Rapid Acting Insulins Companies Ranked by Revenue (2021)
4.1.2 Global Rapid Acting Insulins Revenue by Player (2017-2022)
4.2 Global Rapid Acting Insulins Concentration Ratio (CR)
4.2.1 Rapid Acting Insulins Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Rapid Acting Insulins in 2021
4.2.3 Global Rapid Acting Insulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Rapid Acting Insulins Headquarters, Revenue in Rapid Acting Insulins Business (2017-2022) & (US$ Million) Type
4.3.1 Global Rapid Acting Insulins Headquarters and Area Served
4.3.2 Global Rapid Acting Insulins Companies Revenue in Rapid Acting Insulins Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Rapid Acting Insulins Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Rapid Acting Insulins Market Size by Company
4.5.1 Top Rapid Acting Insulins Players in United States, Ranked by Revenue (2021)
4.5.2 United States Rapid Acting Insulins Revenue by Players (2020, 2021 & 2022)
5 Global Rapid Acting Insulins Market Size by Region
5.1 Global Rapid Acting Insulins Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Rapid Acting Insulins Market Size by Region (2017-2028)
5.2.1 Global Rapid Acting Insulins Market Size by Region: 2017-2022
5.2.2 Global Rapid Acting Insulins Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Rapid Acting Insulins Market Size YoY Growth 2017-2028
6.1.2 North America Rapid Acting Insulins Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Rapid Acting Insulins Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Rapid Acting Insulins Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Rapid Acting Insulins Market Size YoY Growth 2017-2028
6.3.2 Europe Rapid Acting Insulins Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Rapid Acting Insulins Market Size YoY Growth 2017-2028
6.4.2 Latin America Rapid Acting Insulins Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Rapid Acting Insulins Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Rapid Acting Insulins Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Details
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Rapid Acting Insulins Introduction
7.1.4 Eli Lilly Revenue in Rapid Acting Insulins Business (2017-2022)
7.1.5 Eli Lilly Recent Development
7.2 Novo Nordisk
7.2.1 Novo Nordisk Company Details
7.2.2 Novo Nordisk Business Overview
7.2.3 Novo Nordisk Rapid Acting Insulins Introduction
7.2.4 Novo Nordisk Revenue in Rapid Acting Insulins Business (2017-2022)
7.2.5 Novo Nordisk Recent Development
7.3 Sanofi
7.3.1 Sanofi Company Details
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Rapid Acting Insulins Introduction
7.3.4 Sanofi Revenue in Rapid Acting Insulins Business (2017-2022)
7.3.5 Sanofi Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of TablesTable 1. Rapid Acting Insulins Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Rapid Acting Insulins Market Trends
Table 3. Rapid Acting Insulins Market Drivers
Table 4. Rapid Acting Insulins Market Challenges
Table 5. Rapid Acting Insulins Market Restraints
Table 6. Global Rapid Acting Insulins Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Rapid Acting Insulins Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Rapid Acting Insulins Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Rapid Acting Insulins Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Rapid Acting Insulins Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Rapid Acting Insulins Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Rapid Acting Insulins Revenue Share by Player, 2017-2022
Table 13. Global Rapid Acting Insulins Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rapid Acting Insulins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Acting Insulins as of 2021)
Table 15. Top Players of Rapid Acting Insulins in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Rapid Acting Insulins Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Rapid Acting Insulins Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Rapid Acting Insulins Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Rapid Acting Insulins Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Rapid Acting Insulins Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Rapid Acting Insulins Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Rapid Acting Insulins Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Rapid Acting Insulins Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Rapid Acting Insulins Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Rapid Acting Insulins Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Rapid Acting Insulins Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Rapid Acting Insulins Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Rapid Acting Insulins Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Eli Lilly Company Details
Table 31. Eli Lilly Business Overview
Table 32. Eli Lilly Rapid Acting Insulins Product
Table 33. Eli Lilly Revenue in Rapid Acting Insulins Business (2017-2022) & (US$ Million)
Table 34. Eli Lilly Recent Development
Table 35. Novo Nordisk Company Details
Table 36. Novo Nordisk Business Overview
Table 37. Novo Nordisk Rapid Acting Insulins Product
Table 38. Novo Nordisk Revenue in Rapid Acting Insulins Business (2017-2022) & (US$ Million)
Table 39. Novo Nordisk Recent Development
Table 40. Sanofi Company Details
Table 41. Sanofi Business Overview
Table 42. Sanofi Rapid Acting Insulins Product
Table 43. Sanofi Revenue in Rapid Acting Insulins Business (2017-2022) & (US$ Million)
Table 44. Sanofi Recent Development
Table 45. Research Programs/Design for This Report
Table 46. Key Data Information from Secondary Sources
Table 47. Key Data Information from Primary Sources
List of FiguresFigure 1. Rapid Acting Insulins Product Picture
Figure 2. Global Rapid Acting Insulins Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Rapid Acting Insulins Market Size 2017-2028 (US$ Million)
Figure 4. United States Rapid Acting Insulins Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Rapid Acting Insulins Market Size 2017-2028 (US$ Million)
Figure 6. United States Rapid Acting Insulins Market Share in Global 2017-2028
Figure 7. Rapid Acting Insulins Report Years Considered
Figure 8. Product Picture of Lispro
Figure 9. Product Picture of Aspart (NovoLog)
Figure 10. Product Picture of Glulisine (Apidra)
Figure 11. Global Rapid Acting Insulins Market Share by Type in 2022 & 2028
Figure 12. Global Rapid Acting Insulins Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Rapid Acting Insulins Market Share by Type (2017-2028)
Figure 14. United States Rapid Acting Insulins Market Share by Type in 2022 & 2028
Figure 15. United States Rapid Acting Insulins Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Rapid Acting Insulins Market Share by Type (2017-2028)
Figure 17. Product Picture of Type 1 Diabetes
Figure 18. Product Picture of Type 2 Diabetes
Figure 19. Global Rapid Acting Insulins Market Share by Application in 2022 & 2028
Figure 20. Global Rapid Acting Insulins Market Size by Application (2017-2028) & (US$ Million)
Figure 21. Global Rapid Acting Insulins Market Share by Application (2017-2028)
Figure 22. United States Rapid Acting Insulins Market Share by Application in 2022 & 2028
Figure 23. United States Rapid Acting Insulins Market Size by Application (2017-2028) & (US$ Million)
Figure 24. United States Rapid Acting Insulins Market Share by Application (2017-2028)
Figure 25. North America Rapid Acting Insulins Market Size Growth Rate 2017-2028 (US$ Million)
Figure 26. U.S. Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Canada Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Europe Rapid Acting Insulins Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. Germany Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. France Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. U.K. Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Italy Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Russia Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Rapid Acting Insulins Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. China Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Japan Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. South Korea Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. India Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Australia Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Taiwan Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Indonesia Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Thailand Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Malaysia Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Philippines Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Latin America Rapid Acting Insulins Market Size Growth Rate 2017-2028 (US$ Million)
Figure 46. Mexico Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Brazil Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Argentina Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Rapid Acting Insulins Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Turkey Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. U.A.E Rapid Acting Insulins Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Eli Lilly Revenue Growth Rate in Rapid Acting Insulins Business (2017-2022)
Figure 54. Novo Nordisk Revenue Growth Rate in Rapid Acting Insulins Business (2017-2022)
Figure 55. Sanofi Revenue Growth Rate in Rapid Acting Insulins Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed